302 related articles for article (PubMed ID: 27995549)
1. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.
Hidalgo M; Álvarez R; Gallego J; Guillén-Ponce C; Laquente B; Macarulla T; Muñoz A; Salgado M; Vera R; Adeva J; Alés I; Arévalo S; Blázquez J; Calsina A; Carmona A; de Madaria E; Díaz R; Díez L; Fernández T; de Paredes BG; Gallardo ME; González I; Hernando O; Jiménez P; López A; López C; López-Ríos F; Martín E; Martínez J; Martínez A; Montans J; Pazo R; Plaza JC; Peiró I; Reina JJ; Sanjuanbenito A; Yaya R; Carrato A
Clin Transl Oncol; 2017 Jun; 19(6):667-681. PubMed ID: 27995549
[TBL] [Abstract][Full Text] [Related]
2. TTD consensus document on the diagnosis and management of exocrine pancreatic cancer.
Benavides M; Abad A; Ales I; Carrato A; Díaz Rubio E; Gallego J; García-Foncillas J; Grávalos C; Laquente B; Pericay C; Rivera F; Tabernero J; Aranda E
Clin Transl Oncol; 2014 Oct; 16(10):865-78. PubMed ID: 24728654
[TBL] [Abstract][Full Text] [Related]
3. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.
Alemi F; Alseidi A; Scott Helton W; Rocha FG
Curr Probl Surg; 2015 Sep; 52(9):362-98. PubMed ID: 26363649
[No Abstract] [Full Text] [Related]
4. Adjuvant treatment of surgically resectable pancreatic ductal adenocarcinoma.
Tesfaye AA; Philip PA
Clin Adv Hematol Oncol; 2019 Jan; 17(1):54-63. PubMed ID: 30843899
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Seufferlein T; Bachet JB; Van Cutsem E; Rougier P;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii33-40. PubMed ID: 22997452
[No Abstract] [Full Text] [Related]
6. [Overview of revised international consensus guidelines 2012 for the management of IPMN and MCN].
Tamura K; Ohtsuka T; Tanaka M
Nihon Rinsho; 2015 Mar; 73 Suppl 3():400-4. PubMed ID: 25857056
[No Abstract] [Full Text] [Related]
7. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.
Syed AR; Carleton NM; Horne Z; Dhawan A; Bedi G; Kochhar G; Morrissey S; Williams H; Atkinson D; Schiffman S; Monga D; Lupetin A; Kirichenko A; Mitre M; Dhawan M; Kulkarni A; Thakkar S
J Gastrointest Cancer; 2020 Sep; 51(3):836-843. PubMed ID: 31605289
[TBL] [Abstract][Full Text] [Related]
8. Strategies to improve the outcome in locally advanced pancreatic cancer.
Späth C; Nitsche U; Müller T; Michalski C; Erkan M; Kong B; Kleeff J
Minerva Chir; 2015 Apr; 70(2):97-106. PubMed ID: 25658301
[TBL] [Abstract][Full Text] [Related]
9. Role of pancreatic juice cytology in the preoperative management of intraductal papillary mucinous neoplasm of the pancreas in the era of international consensus guidelines 2012.
Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Ideno N; Aso T; Miyasaka Y; Ueda J; Takahata S; Osoegawa T; Igarashi H; Ito T; Ushijima Y; Ookubo F; Oda Y; Mizumoto K; Tanaka M
World J Surg; 2014 Nov; 38(11):2994-3001. PubMed ID: 25037612
[TBL] [Abstract][Full Text] [Related]
10. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
Guo SW; Shen J; Gao JH; Shi XH; Gao SZ; Wang H; Li B; Yuan WL; Lin L; Jin G
Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer.
Vincent A; Herman J; Schulick R; Hruban RH; Goggins M
Lancet; 2011 Aug; 378(9791):607-20. PubMed ID: 21620466
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer: An update on diagnosis and management.
Loveday BPT; Lipton L; Thomson BN
Aust J Gen Pract; 2019 Dec; 48(12):826-831. PubMed ID: 31774983
[TBL] [Abstract][Full Text] [Related]
13. Screening for Pancreatic Cancer: Recommendation Statement.
Am Fam Physician; 2019 Dec; 100(12):Online. PubMed ID: 31845783
[No Abstract] [Full Text] [Related]
14. The actual management of early pancreatic cancer.
Iglesias García J; Lariño-Noia J; Domínguez-Muñoz JE
Minerva Gastroenterol Dietol; 2012 Dec; 58(4):321-30. PubMed ID: 23207609
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma.
Grossberg AJ; Chu LC; Deig CR; Fishman EK; Hwang WL; Maitra A; Marks DL; Mehta A; Nabavizadeh N; Simeone DM; Weekes CD; Thomas CR
CA Cancer J Clin; 2020 Sep; 70(5):375-403. PubMed ID: 32683683
[TBL] [Abstract][Full Text] [Related]
16. Evolving pancreatic cancer treatment: From diagnosis to healthcare management.
Milella M; Bassi C; Boggi U; Brunetti O; Cavaliere A; Crippa S; De Vita F; Falconi M; Frassineti GL; Giommoni E; Macchini M; Malleo G; Silvestris N; Tudisco A; Vasile E; Reni M
Crit Rev Oncol Hematol; 2022 Jan; 169():103571. PubMed ID: 34923121
[TBL] [Abstract][Full Text] [Related]
17. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors for long-term survival in patients with pancreatic ductal adenocarcinoma].
Kawaida H; Fujii H
Nihon Rinsho; 2015 Mar; 73 Suppl 3():181-5. PubMed ID: 25857011
[No Abstract] [Full Text] [Related]
19. The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer.
Gruhl JD; Garrido-Laguna I; Francis SR; Affolter K; Tao R; Lloyd S
Cancer Med; 2020 Mar; 9(5):1703-1711. PubMed ID: 31945808
[TBL] [Abstract][Full Text] [Related]
20. A pancreatic cancer multidisciplinary clinic: insights and outcomes.
Schiffman SC; Abberbock S; Winters S; Valko C; Steve J; Zureikat AH; Zeh HJ; Hogg ME
J Surg Res; 2016 May; 202(2):246-52. PubMed ID: 27229097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
